Thymic expression of the main immunogenic region of titin in thymomatous myasthenia gravis

Journal of International Medical Research

Volumn 38, Issue 4, 2010, Pages 1324-1332

  He, Z F ^a   Lv, W ^a   Qiao, J ^b   Chen, Z M ^b   Pang, L W ^b   Chen, X J ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Aetiology; Connectin; Immunohistochemistry; Myasthenia gravis; Thymoma; Titin

Indexed keywords

CONNECTIN;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CELL COUNT; CHILD; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MALE; MYASTHENIA GRAVIS; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN STRUCTURE; THYMOMA;

EID: 77957741053     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800414     Document Type: Article

References (22)

1. Drachman DB: Myasthenia gravis. N Engl J Med 1994; 330: 1797-1810.
2. Meriggioli MN, Sanders DB: Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009; 8: 475-490.
3. Voltz RD, Albrich WC, Nagele A, et al: Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology 1997; 49: 1454-1457.
4. Aarli JA, Stefansson K, Marton LS, et al: Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 1990; 82: 284-288.
5. Chen XJ, Qiao J, Xiao BG, et al: The significance of titin antibodies in myasthenia gravis: correlation with thymoma and severity of myasthenia gravis. J Neurol 2004; 251: 1006-1011.
6. Labeit S, Kolmerer B: Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 1995; 270: 293-296.
7. Aarli JA, Gilhus NE, Hofstad H: CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis? Acta Neurol Scand 1987; 63: 55-57.
8. Gautel M, Lakey A, Barlo DP, et al: Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology 1993; 43: 1581-1585.
9. Skeie GO, Freiburg A, Kolmerer B, et al: Titin transcripts in thymomas. Ann NY Acad Sci 1998; 841: 422-426.
10. Osserman KE, Genkins G: Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971; 38: 497-537.
11. Bernatz PE, Harrison EG, Clagett OT: Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg 1961; 42: 424-444.
12. Chen XJ, Lu CZ, Qiao J, et al: cDNA cloning expression of MGT-30 and its significance in myasthenia gravis with thymoma. Shanghai J Immunol 2001; 21: 267-270 [in Chinese].
13. Krajewska M, Krajewski S, Epstein JI, et al: Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 1996; 148: 1567-1576.
14. Marx A, Wilisch A, Schultz A, et al: Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Am J Pathol 1996; 148: 1839-1850.
15. Schluep M, Willcox N, Vincent A, et al: Acetylcholine in human thymic myoid cells in situ: an immunologic study. Ann Neurol 1987; 22: 212-221.
16. Kirchener T, Hoppe F, Schalke B, et al: Microenvironment of thymic myoid cells in myasthenia gravis. Virchows Arch B Cell Pathol Incl Mol Pathol 1988; 54: 295-302.
17. McFarlin DE, Barlow M, Strauss AJ: Antibodies to muscle and thymus in nonmyasthenic patients with thymoma. N Engl J Med 1966; 275: 1321-1326.
18. Marx A, Kirchner T, Hoppe F, et al: Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis. Am J Pathol 1989; 134: 865-877.
19. Willcox N: Myasthenia gravis. Curr Opin Immunol 1993; 5: 910-917.
20. Gilhus NE, Willcox N, Harcourt G, et al: Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. J Neuroimmunol 1995; 56: 65-76.
21. Skeie GO, Aarli JA, Matre R, et al: Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin. Eur J Neurol 1997; 4: 131-137.
22. Pescarmona E, Rosati S, Pisacane A, et al: Microscopic thymoma: histological evidence of multifocal cortical and medullary origin. Histopathology 1992; 20: 263-266.